DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vantas (Histrelin Acetate Implant) - News

 
 



News related to Vantas (Histrelin Implant) and/or conditions it is approved for

New radiotherapy regime for prostate cancer could save NHS tens of millions per year
Source: Prostate / Prostate Cancer News From Medical News Today [2016.06.21]
A shorter course of prostate cancer radiotherapy, involving fewer hospital visits and higher individual doses of radiotherapy, is as effective as the current standard treatment for both survival...

Prostate Cancer: Informed Decisions or Information Overload?
Source: MedPage Today Oncology/Hematology [2016.06.17]
(MedPage Today) -- To biopsy, or not to biopsy -- a Shakespearean dilemma

Single Mid-Life PSA Predicts Lethal Prostate Cancer (CME/CE)
Source: MedPage Today Oncology/Hematology [2016.06.17]
(MedPage Today) -- Suggests new approach to screening

Laser ablation becomes increasingly viable treatment for prostate cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2016.06.13]
Prostate cancer patients may soon have a new option to treat their disease: laser heat.

Research reveals prostate cancer radiation treatment can be shortened by 50% with no loss of effectiveness
Source: Prostate / Prostate Cancer News From Medical News Today [2016.06.08]
A shorter 4-week radiation regimen is non-inferior to the standard 8-week regimen when it comes to prostate cancer treatment, an Ontario-led study has found.

Study finds that higher BMI and waist circumference are associated with increased risk of aggressive prostate cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2016.06.03]
A study of almost 150,000 men from 8 European countries, presented at this year's European Obesity Summit (Gothenburg, 1-4 June) shows that higher body mass index (BMI) and waist circumference are...

Imaging biomarker distinguishes prostate cancer tumor grade
Source: Prostate / Prostate Cancer News From Medical News Today [2016.06.02]
Enhanced imaging tool has potential to detect, grade, stage and guide treatment options.

Prostate Cancer Symptoms, Treatment, and Survival Rates
Source: MedicineNet Benign Prostatic Hyperplasia Specialty [2016.06.01]
Title: Prostate Cancer Symptoms, Treatment, and Survival Rates
Category: Slideshows
Created: 12/1/2010 5:22:00 PM
Last Editorial Review: 6/1/2016 12:00:00 AM

FDA approves new diagnostic imaging agent to detect recurrent prostate cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.31]
The U.S. Food and Drug Administration has approved Axumin, a radioactive diagnostic agent for injection.

Genetic biomarker may predict nerve pain side effects associated with prostate cancer treatment
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.16]
New study finds genetic alterations in the VAC14 gene are associated with an increased risk of docetaxel-induced peripheral neuropathy in prostate cancer patients.

Radiotherapy halves deaths from prostate cancer 15 years after diagnosis
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.10]
A longitudinal Nordic study, comparing the results of hormone (antiandrogen) therapy with or without the addition of local radiotherapy, shows that a combination of treatments halves the risk of...

Could 'Breast Cancer Genes' Play Role in Prostate Cancer, Too?
Source: MedicineNet Prostate Cancer Specialty [2016.05.10]
Title: Could 'Breast Cancer Genes' Play Role in Prostate Cancer, Too?
Category: Health News
Created: 5/9/2016 12:00:00 AM
Last Editorial Review: 5/10/2016 12:00:00 AM

BRCA gene mutations associated with increased prostate cancer risk
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.09]
Though predominantly known for their increased associations with breast cancer risk, germline mutations in the BRCA1 and BRCA2 genes are also associated with an increased susceptibility to other...

Prostate cancer: Testosterone therapy 'does not increase aggressive disease risk'
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.09]
A study using Swedish data finds men prescribed testosterone for over a year had no overall rise in prostate cancer risk, and they showed a 50 percent fall in aggressive disease.

New data highlight shifts in diagnosis and management of prostate cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.07]
Three new studies being presented during this year's Annual Scientific Meeting of the American Urological Association highlight differing approaches in the diagnosis and management of prostate...

Patient-physician communication is critical for prostate cancer survivors' health
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.04]
For prostate cancer patients who had their prostates surgically removed, patient-physician communication was key for helping them cope with their disease and for improving their health-related...

Prostate cancer: new drugs show promise against aggressive, resistant forms
Source: Pharma Industry / Biotech Industry News From Medical News Today [2016.05.03]
Tests in mice show that new drugs called Hsp90 inhibitors can disable a mechanism in prostate cancer cells that allows them to evade standard treatment.

Potential cause identified for prostate cancer treatment resistance among African-American men
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.02]
Improper functioning of the mitochondria, a cell's source of energy, may help account for the fact that African-American men with prostate cancer respond poorly to the same conventional therapies...

New cancer drugs could treat lethal resistant prostate cancers
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.01]
Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class of cancer drug designed to overcome drug resistance, a new study...

Quality of prostate cancer care improving in Victoria
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.01]
Research published in Medical Journal of Australia has found that the overall quality of care for prostate cancer patients has improved in Victoria.

VolitionRx announces study results showing NuQ® blood test detects prostate cancer early with significantly higher accuracy than PSA test
Source: Prostate / Prostate Cancer News From Medical News Today [2016.04.21]
VolitionRx Limited has announced that a single NuQ® biomarker assay detected 71% of early stage I prostate cancer cases at 93% specificity.

UT Southwestern research shows 98 percent cure rate for prostate cancer using SBRT
Source: Prostate / Prostate Cancer News From Medical News Today [2016.04.19]
A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT...

Drop in cigarette smoking linked to decline in prostate cancer deaths
Source: Prostate / Prostate Cancer News From Medical News Today [2016.04.14]
Declines in prostate cancer deaths from 1999 through 2010 parallel declines in the number of men who smoke cigarettes, Johns Hopkins researchers report.

High-Dose Radiation May Be No Better for Low-Risk Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2016.04.07]
Title: High-Dose Radiation May Be No Better for Low-Risk Prostate Cancer
Category: Health News
Created: 4/6/2016 12:00:00 AM
Last Editorial Review: 4/7/2016 12:00:00 AM

Prostate Cancer Screening, Detection Both Down in U.S., Studies Say
Source: MedicineNet Prostate Specific Antigen Specialty [2015.11.17]
Title: Prostate Cancer Screening, Detection Both Down in U.S., Studies Say
Category: Health News
Created: 11/17/2015 12:00:00 AM
Last Editorial Review: 11/17/2015 12:00:00 AM

Prostate Cancer
Source: MedicineNet Benign Prostatic Hyperplasia Specialty [2015.11.12]
Title: Prostate Cancer
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 11/12/2015 12:00:00 AM

UCLA researchers find a wide variation in costs to treat low-risk prostate cancer
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2015.11.03]
Now, for the first time, UCLA researchers have described cost across an entire care process for low-risk prostate cancer - from the time a patient checks in for his first appointment to his...

Early Chemo May Boost Survival in Advanced Prostate Cancer
Source: MedicineNet docetaxel Specialty [2015.05.15]
Title: Early Chemo May Boost Survival in Advanced Prostate Cancer
Category: Health News
Created: 5/14/2015 12:00:00 AM
Last Editorial Review: 5/15/2015 12:00:00 AM

FDA OKs PET Agent for Prostate Cancer
Source: MedPage Today Product Alert [2012.09.12]
WASHINGTON -- The FDA has approved the positron emission tomography (PET) imaging agent Choline C 11 Injection for production and use in detecting recurrent prostate cancer.

Lifestyle, diet may stop or reverse prostate cancer progression
Source: The Doctors Lounge - Urology
The research is the first randomized, controlled trial to show that lifestyle changes may affect cancer progression.

Which ADT Is Smarter for the Heart?
Source: Medscape Pharmacists Headlines [2016.06.20]
When considering options for androgen deprivation therapy in prostate cancer, GnRH antagonists may be better choices than agonists for patients with cardiovascular risk, says Dr Gerald Chodak.
Medscape Urology

Study suggests chemotherapy after radical prostatectomy may benefit men who are at high risk for relapse
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.07]
Not all men with prostate cancer benefit from adjuvant chemotherapy after radical prostatectomy; however, African American men and men with a higher tumor stage may, according to a new U.S.

New technology quantifies effects of prostate tumor laser ablation
Source: Prostate / Prostate Cancer News From Medical News Today [2016.04.20]
Effort to understand risks of treatment, and prognostic clues to long-term outcomes. Prostate cancers are either low-grade, low-risk forms that may be monitored but otherwise untreated.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015